CHRISTIAN CLINARD: Open Payments
NPI 1598354565 · MACON, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$617 in 22 payments from 7 companies in 2025. Trend: 2023 $460 · 2024 $419 · 2025 $617
Food & beverage: $617
| Company | Payments | Amount |
|---|---|---|
| Ardelyx, Inc. | 9 | $208 |
| Janssen Biotech, Inc. | 3 | $195 |
| PFIZER INC. | 4 | $89 |
| ABBVIE INC. | 2 | $43 |
| GENZYME CORPORATION | 1 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $31 |
| EVOKE PHARMA, INC. | 1 | $16 |
Products named: IBSRELA, TREMFYA, XELJANZ, LINZESS, DUPIXENT, EOHILIA, VELSIPITY, GIMOTI.
Industry payments across GA — which companies pay providers there.
